Echo Therapeutics (NSDQ:ECTE) said this week it has beaten a lawsuit which the company said could drain its coffers and leave it unable to continue. The Iselin, N.J.-based company was facing a case in the U.S. District Court for Southern New York related to “various violations of the securities laws, theft of trade secrets, breach of […]
Echo Therapeutics touts win in whistleblower case
Echo Therapeutics (NSDQ:ECTE) this week announced a court ruling in its favor, denying a restrictive injunction and giving the company breathing room after it said last week that a long defense could drain its coffers and leave its future uncertain. The company was facing a case in the U.S. District Court for Southern New York related […]
Echo Therapeutics faces uncertain future in whistleblower case
Echo Therapeutics (NSDQ:ECTE) said today that its future may be in jeopardy after getting hit with a restrictive injunction related to a whistleblower case alleging securities violations, theft of trade secrets and more. The company said it is facing a case in the U.S. District Court for Southern New York related to “various violations of the […]
Siemens US CEO Spiegel to step down, Marks & Davis step up | Personnel Moves November 30, 2016
Siemens (NYSE:SI) said today that its U.S. CEO Eric Spiegel is retiring at the end of the year, with Lisa Davis slated to take the role of chair & CEO of the US-based Siemens Corporation, while Judith Marks will act as Siemens CEO U.S. Both changes are slated to go into effect January 1, 2017, according […]
Echo Therapeutics delists from NASDAQ, moves to OT
Echo Therapeutics (NSDQ:ECTE) said last week that it will move its shares from the NASDAQ exchange to the OTCQB Venture Market after failing to meet NASDAQ’s shareholder equity requirement. The Iselin, N.J.-based company had until July 5 to show $2.5 million in shareholder equity but failed to meet the deadline. ECTE shares are due to begin […]
Echo Therapeutics launches pre-regulatory CGM component testing
Echo Therapeutics (NSDQ:ECTE) said today it began stand-alone component and integrated testing of its NextGen continuous glucose monitoring system prototypes and selected a clinical research organization to aid it in arranging a regulatory and clinical strategy. The Iselin, N.J.-based company is developing a non-invasive, wireless CGM for use in the outpatient diabetes market and the fitness, […]
Oversight board OKs trial for Echo Therapeutics non-invasive CGM
Echo Therapeutics (NSDQ:ECTE) said today it won Institutional Review Board approval to expand testing of its non-invasive continuous glucose monitor, which can now include both pediatric and adult subjects. The Iselin, N.J.-based company is developing a non-invasive, wireless CGM for use in the outpatient diabetes market and the fitness, weight loss and personal lifestyle wearable-health space. […]
Echo Therapeutics breaks lease on Mass. lab space
Echo Therapeutics (NSDQ:ECTE) said last week it is moving its research lab from Franklin, Mass. to Littleton, Mass. and terminating its previous lease in the process. The Philadelphia-based developer of wireless glucose monitors and wearable health and fitness devices said it paid $150,000 to break the lease on its previous 37,050 square foot research facility in Franklin. […]
Echo Therapeutics settles spat with ex-CEO Mooney
Echo Therapeutics (NSDQ:ECTE) today said it agreed to settle an ongoing dispute with former president & CEO Dr. Patrick Mooney that arose after his sudden departure in August 2013. Mooney, a surgeon by training before he headed to the world of high finance and Wall Street, had been running things at Echo since a 2007 merger with Sontra […]
Amniox Medical taps ex-Smith & Nephew honcho Dugan for CEO | Personnel Moves
Ex-Boston Scientific CEO Tobin joins Oxford Immunotec board | Personnel Moves
- 1
- 2
- 3
- …
- 7
- Next Page »
